Tearsheet

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -57%
Weak multi-year price returns
2Y Excs Rtn is -127%, 3Y Excs Rtn is -144%
Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -1.3 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.2%
1 Megatrend and thematic drivers
Megatrends include E-commerce & Digital Retail, Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Online Marketplaces, Show more.
  Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 932%
2   Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -0.5%, Rev Chg QQuarterly Revenue Change % is -11%
3   Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -5.8%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -7.3%
4   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -48%
0 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -57%
1 Megatrend and thematic drivers
Megatrends include E-commerce & Digital Retail, Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Online Marketplaces, Show more.
2 Weak multi-year price returns
2Y Excs Rtn is -127%, 3Y Excs Rtn is -144%
3 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -1.3 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.2%
4 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 932%
5 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -0.5%, Rev Chg QQuarterly Revenue Change % is -11%
6 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -5.8%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -7.3%
7 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -48%

Valuation, Metrics & Events

GOCO Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Here are the key points highlighting why GoHealth (GOCO) stock moved by -41.5% from approximately August 31, 2025, to December 4, 2025:

1. GoHealth reported a significant decline in its Third Quarter 2025 revenue and a widening net loss. The company's total revenue plummeted by 71.1% year-over-year to $34.19 million for Q3 2025, and it swung to a net loss of $165.85 million, compared to a net income of $6.78 million in the same period a year prior. These results substantially missed analyst expectations, leading to a sharp drop in the stock price.

2. The company implemented a deliberate pullback in Medicare Advantage enrollment volume. GoHealth's management intentionally reduced its Medicare Advantage volume to prioritize member quality, retention, and platform efficiency. This strategic shift, while aimed at long-term stability, directly impacted near-term enrollment and revenue growth.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
GOCO Return--72%-82%28%0%-78%-99%
Peers Return5%27%-3%7%19%-11%47%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
GOCO Win Rate40%42%25%50%58%30% 
Peers Win Rate58%65%38%43%58%42% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
GOCO Max Drawdown--76%-91%-27%-44%-83% 
Peers Max Drawdown-27%-9%-19%-7%-1%-14% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: NP, WTW, MMC, AON, AJG.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)

How Low Can It Go

Unique KeyEventGOCOS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-97.9%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven4763.2%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-54.3%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven118.7%51.3%
2020 Covid PandemicTime to BreakevenTime to BreakevenNot Fully Recovered days148 days

Compare to NP, WTW, MMC, AON, AJG


In The Past

GoHealth's stock fell -97.9% during the 2022 Inflation Shock from a high on 1/8/2021. A -97.9% loss requires a 4763.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About GoHealth (GOCO)

Better Bets than GoHealth (GOCO)

Latest Trefis Analyses

TitleTopic
0DASHBOARDS 
1Can GoHealth Stock Recover If Markets Fall?Return
Title
0ARTICLES

Trade Ideas

Select past ideas related to GOCO. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
WU_11212025_Dip_Buyer_FCFYield11212025WUWestern UnionDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
3.4%3.4%-0.4%
COIN_11212025_Monopoly_xInd_xCD_Getting_Cheaper11212025COINCoinbase GlobalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
9.5%9.5%0.0%
PYPL_11142025_Dip_Buyer_FCFYield11142025PYPLPayPalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
0.1%0.1%-7.5%
V_11142025_Monopoly_xInd_xCD_Getting_Cheaper11142025VVisaMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
-0.1%-0.1%-2.7%
WD_11072025_Dip_Buyer_ValueBuy11072025WDWalker & DunlopDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-7.7%-7.7%-11.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
WU_11212025_Dip_Buyer_FCFYield11212025WUWestern UnionDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
3.4%3.4%-0.4%
COIN_11212025_Monopoly_xInd_xCD_Getting_Cheaper11212025COINCoinbase GlobalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
9.5%9.5%0.0%
PYPL_11142025_Dip_Buyer_FCFYield11142025PYPLPayPalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
0.1%0.1%-7.5%
V_11142025_Monopoly_xInd_xCD_Getting_Cheaper11142025VVisaMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
-0.1%-0.1%-2.7%
WD_11072025_Dip_Buyer_ValueBuy11072025WDWalker & DunlopDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-7.7%-7.7%-11.0%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for GoHealth

Peers to compare with:

Financials

GOCONPWTWMMCAONAJGMedian
NameGoHealth Neptune .Willis T.Marsh & .Aon Arthur J. 
Mkt Price2.9923.74316.53183.87344.45245.36214.62
Mkt Cap0.0-31.090.374.362.962.9
Rev LTM822-9,80726,45317,02812,47112,471
Op Inc LTM-1-2,2686,1464,4542,6262,626
FCF LTM-60-1,3814,8253,0401,9721,972
FCF 3Y Avg18-1,1764,0572,9561,9381,938
CFO LTM-48-1,6035,0873,2842,1202,120
CFO 3Y Avg31-1,4124,3983,1992,1032,103

Growth & Margins

GOCONPWTWMMCAONAJGMedian
NameGoHealth Neptune .Willis T.Marsh & .Aon Arthur J. 
Rev Chg LTM17.5%--0.0%10.5%14.1%13.8%13.8%
Rev Chg 3Y Avg-0.5%-3.5%8.3%11.1%13.3%8.3%
Rev Chg Q-11.2%--0.0%11.5%7.4%16.0%7.4%
QoQ Delta Rev Chg LTM-1.4%--0.0%2.5%1.6%3.7%1.6%
Op Mgn LTM-0.2%-23.1%23.2%26.2%21.1%23.1%
Op Mgn 3Y Avg-17.8%-21.0%23.1%27.1%19.7%21.0%
QoQ Delta Op Mgn LTM-0.7%-0.6%-0.3%0.5%0.4%0.4%
CFO/Rev LTM-5.8%-16.3%19.2%19.3%17.0%17.0%
CFO/Rev 3Y Avg6.0%-14.6%18.1%21.5%19.4%18.1%
FCF/Rev LTM-7.3%-14.1%18.2%17.9%15.8%15.8%
FCF/Rev 3Y Avg4.2%-12.2%16.7%19.9%17.8%16.7%

Valuation

GOCONPWTWMMCAONAJGMedian
NameGoHealth Neptune .Willis T.Marsh & .Aon Arthur J. 
Mkt Cap0.0-31.090.374.362.962.9
P/S0.1-3.53.74.56.63.7
P/EBIT2.9-11.415.318.031.715.3
P/E-2.3-16.024.028.350.024.0
P/CFO-1.3-21.119.523.438.721.1
Total Yield-43.9%-7.0%5.8%4.3%2.4%4.3%
Dividend Yield0.0%-0.8%1.7%0.8%0.4%0.8%
FCF Yield 3Y Avg-6.1%-4.1%4.0%4.1%3.2%4.0%
D/E9.9-0.20.20.20.20.2
Net D/E9.3-0.10.20.1-0.00.1

Returns

GOCONPWTWMMCAONAJGMedian
NameGoHealth Neptune .Willis T.Marsh & .Aon Arthur J. 
1M Rtn-21.7%-6.0%0.8%3.8%1.4%1.0%0.9%
3M Rtn-38.2%-25.8%-3.0%-10.0%-7.7%-19.2%-14.6%
6M Rtn-49.0%-25.8%2.9%-20.2%-7.2%-26.7%-23.0%
12M Rtn-75.1%-25.8%-2.7%-18.8%-9.9%-20.2%-19.5%
3Y Rtn-75.8%-25.8%32.9%10.6%15.0%25.0%12.8%
1M Excs Rtn-21.7%-6.0%0.8%3.8%1.4%1.0%0.9%
3M Excs Rtn-44.2%-31.2%-9.1%-15.7%-12.9%-23.6%-19.7%
6M Excs Rtn-63.7%-40.5%-11.8%-34.9%-21.9%-41.5%-37.7%
12M Excs Rtn-90.2%-39.4%-14.1%-33.5%-24.9%-34.3%-33.9%
3Y Excs Rtn-144.0%-98.6%-35.4%-58.6%-57.2%-44.4%-57.9%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Medicare products735632   
Medicare Revenue  898  
Other Revenue  164  
Individual and Family Plans and Other-External channel   2213
Individual and Family Plans and Other-Internal channel   3221
Medicare-External   15659
Medicare-Internal   667215
Total7356321,062877308


Price Behavior

Short Interest

Short Interest: As Of Date11142025
Short Interest: Shares Quantity243,505
Short Interest: % Change Since 103120257.2%
Average Daily Volume58,779
Days-to-Cover Short Interest4.14
Basic Shares Quantity10,830,000
Short % of Basic Shares2.2%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025812202510-Q 6/30/2025
3312025516202510-Q 3/31/2025
12312024227202510-K 12/31/2024
93020241107202410-Q 9/30/2024
6302024808202410-Q 6/30/2024
3312024509202410-Q 3/31/2024
12312023314202410-K 12/31/2023
93020231109202310-Q 9/30/2023
6302023810202310-Q 6/30/2023
3312023509202310-Q 3/31/2023
12312022323202310-K 12/31/2022
93020221114202210-Q 9/30/2022
6302022816202210-Q 6/30/2022
3312022510202210-Q 3/31/2022
12312021316202210-K 12/31/2021
93020211110202110-Q 9/30/2021